Latest Breaking News On - Ivana spotakova - Page 1 : comparemela.com

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders

Showcasing wilate® at EAHAD 2024WIL-31 is the largest prospective prophylaxis study in VWD with an on-demand run-in study as an intra-individual patient .

Switzerland generalNordrhein westfalenThromb haemostIvana spotakovaOlaf walterLarisa belyanskayaRobertf sidonio jrHead of international business units at octapharmaSatellite symposiumSenior vice presidentAna bobanCsongor kissPanorama roomBoard memberInternational business unitsFull prescribing information

Octapharma AG: Publication of data from WIL-31 study marks a milestone in improving long-term care for patients with severe von Willebrand disease (VWD)

Octapharma AG: Publication of data from WIL-31 study marks a milestone in improving long-term care for patients with severe von Willebrand disease (VWD)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Nordrhein westfalenSwitzerland generalRobertf sidonio jrStefan klotterIvana spotakovaPrnewswire octapharmaSigurd knaubGlobal communicationsAflac cancer blood disorders centerBlood advancesPrincipal investigatorMedical directorAflac cancerBlood disorders centerAssociate professorEmory university school

Octapharma to present clinical and scientific data that advances our understanding and treatment of bleeding disorders at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), which takes place in Frankfurt, Germany, from February 6 - 9, 2024

LACHEN, Switzerland, Jan. 18, 2024 /PRNewswire/

Switzerland generalNordrhein westfalenThromb haemostIvana spotakovaLarisa belyanskayaRobertf sidonio jrOlaf walterHead of international business units at octapharmaSatellite symposiumSenior vice presidentAna bobanPanorama roomBoard memberInternational business unitsFull prescribing informationTher adv hematol

Octapharma Puts a Spotlight on the Infection Burden in Patients With Chronic Lymphocytic Leukaemia (CLL) at the European Hematology Association (EHA) Hybrid Congress 2023

Real-world data and expert perspectives on state-of-the-art clinical practice for the management of infection in patients with CLL will be showcased during the Octapharma Update-in-Hematology session

United statesSwitzerland generalMecklenburg vorpommernIvana spotakovaOlaf walterStephan stilgenbauerLivio trentinGuillain barrStefan klotterHaematology unit at padua universityCorporate communicationsCancer centre in ulmCongress onUniversity of paduaOctapharma update in hematologyLymphocytic leukemia

European Authorities Approve Lyophilized S/D Treated Plasma OctaplasLG® for Pre-Hospital Transfusion

European Authorities Approve Lyophilized S/D Treated Plasma OctaplasLG® for Pre-Hospital Transfusion
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Switzerland generalOliver hegenerIvana spotakovaWorld health organizationVice presidentTrauma acute careRev disPrehospital plasma transfusion with survivalPost hoc analysisCommunications manager